skip to content

Market News

Dechra options exercised

30 November 2016 08:45

Dechra Pharmaceuticals directors Ian Page and Tony Griffin have exercised 124,375 and 32,849 nil cost share options respectively. The options were granted to them on 27 November 2013 under the Dechra Pharmaceuticals PLC Long Term Incentive Plan. The exercise of the options was subject to the achievement of performance conditions which vested at 96.25% of the total award.

At 8:45am: (LON:DPH) Dechra Pharmaceuticals PLC share price was +4p at 1276p

Story provided by

Related Company: DPH

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.